The expression of both domains of the 69/71 kDa 2',5' oligoadenylate synthetase generates a catalytically active enzyme and mediates an anti- viral response

European Journal of Biochemistry

Volumn 262, Issue 1, 1999, Pages 155-165

  Marié, Isabelle ^a,c   Rebouillat, Dominique ^a   Hovanessian, Ara G ^a,b  

^a CNRS   (France)

^b INSTITUT PASTEUR   (France)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2',5' oligoadenylate synthetase; 2',5' oligoadenylate triphosphate; Double stranded RNA; Interferon; Virus resistance

Indexed keywords

INTERFERON; SYNTHETASE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; INFECTION RESISTANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; ANTIVIRAL AGENTS; CATALYSIS; CELL LINE; CLONE CELLS; HUMANS; PROTEIN ISOFORMS; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0033563240     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00361.x     Document Type: Article

References (61)

1. 1. Hovanessian, A.G., Brown, R.E. & Kerr, I.M. (1977) Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature 268, 537-540.
2. 2. Kerr, I.M. & Brown, R.E. (1978) pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells. Proc. Natl Acad. Sci. USA 75, 256-260.
3. 3. Hovanessian, A.G. (1991) Interferon-induced and double-stranded RNA-activated enzymes: a specific protein kinase and 2′,5′-oligoadenylate synthetases. J. Interferon Res. 11, 199-205.
4. 4. Rebouillat, D. & Hovanessian, A.G. (1999) The human 2′,5′-oligoadenylate synthetase family: interferon induced proteins with unique enzymatic proprieties. J. Interferon Cytokine Res. 19, 295-308.
5. 5. Clemens, M.J. & Williams, B.R. (1978) Inhibition of cell-free protein synthesis by pppA2′p5′A2′p5′A: a novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 13, 565-572.
6. 6. Zhou, A., Hassel, B.A. & Silverman, R.H. (1993) Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72, 753-765.
7. 7. Sen, G.C. & Lengyel, P. (1992) The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 267, 5017-5020.
8. 8. Kerr, I.M. (1987) The 2-5A system: a personal view. J. Interferon Res. 7, 505-510.
9. 9. Hovanessian, A.G., Wood, J., Meurs, E. & Montagnier, L. (1979) Increased nuclease activity in cells treated with pppA2′p5′A2′p5′ A. Proc. Natl Acad. Sci. USA 76, 3261-3265.
10. 10. Schmidt, A., Chernajovsky, Y., Shulman, L., Federman, P., Berissi, H. & Revel, M. (1979) An interferon-induced phosphodiesterase degrading (2′-5′) oligoisoadenylate and the C-C-A terminus of tRNA. Proc. Natl Acad. Sci. USA 76, 4788-4792.
11. 11. Bisbal, C., Martinand, C., Silhol, M., Lebleu, B. & Salehzada, T. (1995) Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway. J. Biol. Chem. 270, 13308-13317.
12. 12. Jacobs, B.L. & Langland, J.O. (1996) When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219, 339-349.
13. 13. Marié, I., Svab, J. & Hovanessìan, A.G. (1990) The binding of the 69-and 100-kD forms of 2′,5′-oligoadenylate synthetase to different polynucleotides. J. Interferon Res. 10, 571-578.
14. 14. Maitra, R.K., McMillan, N.A., Desai, S., McSwiggen, J., Hovanessian, A.G., Sen, G., Williams, B.R. & Silverman, R.H. (1994) HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204, 823-827.
15. 15. Williams, B.R., Golgher, R.R., Brown, R.E., Gilbert, C.S. & Kerr, I.M. (1979) Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells. Nature 282, 582-586.
16. 16. Nilsen, T.W., Maroney, P.A. & Baglioni, C. (1982) Inhibition of protein synthesis in reovirus-infected HeLa cells with elevated levels of interferon-induced protein kinase activity. J. Biol. Chem. 257, 14593-14596.
17. 17. Stark, G.R., Dower, W.J., Schimke, R.T., Brown, R.E. & Kerr, I.M. (1979) 2-5A synthetase: assay, distribution and variation with growth or hormone status. Nature 278, 471-473.
18. 18. Krust, B., Rivière, Y. & Hovanessian, A.G. (1982) p67K kinase in different tissues and plasma of control and interferon-treated mice. Virology 120, 240-246.
19. 19. Williams, B.R.G. & Silverman, R.H. (1985) The 2-5A System. Alan R. Liss, Inc., New York.
20. 20. Williams, B.R. & Kerr, I.M. (1978) Inhibition of protein synthesis by 2′-5′ linked adenine oligonucleotides in intact cells. Nature 276, 88-90.
21. n. Virology 101, 81-90.
22. 22. Coccia, E.M., Romeo, G., Nissim, A., Marziali, G., Albertini, R., Affabris, E., Battistini, A., Fiorucci, G., Orsatti, R., Rossi, G.B. & et, a. (1990) A full-length murine 2-5A synthetase cDNA transfected in NIH-3T3 cells impairs EMCV but not VSV replication. Virology 179, 228-233.
23. 23. Chebath, J., Benech, P., Revel, M. & Vigneron, M. (1987) Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330, 587-588.
24. 24. Hassel, B.A., Zhou, A., Sotomayor, C., Maran, A. & Silverman, R.H. (1993) A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12, 3297-3304.
25. 25. Laurence, L., Marti, J., Roux, D. & Cailla, H. (1984) Immunological evidence for the in vivo occurrence of (2′-5′) adenylyladenosine oligonucleotides in eukaryotes and prokaryotes. Proc. Natl Acad. Sci. USA 81, 2322-2326.
26. 26. Laurence, L., Roux, D., Cailla, H., Riviere, Y., Marcovistz, R. & Hovanessian, A. (1985) Comparison of the effects of rabies virus infection and of combined interferon and poly (I)-poly (C) treatment on the levels of 2′,5-adenyladenosine oligonucleotides in different ′ organs of mice. Virology 143, 290-299.
27. 27. Rysiecki, G., Gewert, D.R. & Williams, B.R. (1989) Constitutive expression of a 2′,5′-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression. J. Interferon Res. 9, 649-657.
28. 28. Kimchi, A., Shure, H., Lapidot, Y., Rapoport, S., Panet, A. & Revel, M. (1981) Antimitogenic effects of interferon and (2′-5′)-oligoadenylate in synchronized 3T3 fibroblasts. FEBS Lett. 134, 212-216.
29. 29. Kimchi, A., Shure, H. & Revel, M. (1981) Anti-mitogenic function of interferon-induced (2′-5′) oligo (adenylate) and growth-related variations in enzymes that synthesize and degrade this oligonucleotide. Eur. J. Biochem. 114, 5-10.
30. 30. Ferbus, D., Testa, U., Titeux, M., Louache, F. & Thang, M.N. (1985) Induction of (2′-5′) oligoadenylate synthetase activity during granulocyte and monocyte differentiation. Mol. Cell Biochem. 67, 125-133.
31. 31. Krause, D., Silverman, R.H., Jacobsen, H., Leisy, S.A., Dieffenbach, C.W. & Friedman, R.M. (1985) Regulation of ppp (A2′p)nA-dependent RNase levels during interferon treatment and cell differentiation. Eur. J. Biochem. 146, 611-618.
32. 32. Castelli, J.C., Hassel, B.A., Wood, K.A., Li, X.L., Amemiya, K., Dalakas, M.C., Torrence, P.F. & Youle, R.J. (1997) A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med. 186, 967-972.
33. 33. Castelli, J.C., Hassel, B.A., Maran, A., Paranjape, J., Hewitt, J.A., Li, X.L., Hsu, Y.T., Silverman, R.H. & Youle, R.J. (1998) The role of 2′-5′ oligoadenylate-activated ribonuclease 1 in apoptosis. Cell Death Diff. 5, 313-320.
34. 34. Chebath, J., Benech, P., Hovanessian, A., Galabru, J. & Revel, M. (1987) Four different forms of interferon-induced 2′,5′-oligo (A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262, 3852-3857.
35. 35. Hovanessian, A.G., Laurent, A.G., Chebath, J., Galabru, J., Robert, N. & Svab, J. (1987) Identification of 69-kd and 100-kd forms of 2-5A synthetase in interteron-treated human cells by specific monoclonal antibodies. EMBO J. 6, 1273-1280.
36. 36. Hovanessian, A.G., Svab, J., Marie, I., Robert, N., Chamaret, S. & Laurent, A.G. (1988) Characterization of 69- and 100-kDa forms of 2-5A-synthetase from interferon-treated human cells. J. Biol. Chem. 263, 4959-4959.
37. 37. Yang, K., Samanta, H., Dougherty, J., Jayaram, B., Broeze, R. & Lengyel, P. (1981) Interferons, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human (2′-5′) (a)n synthetase. J. Biol. Chem. 17, 9324-9328.
38. 38. Benech, P., Merlin, G., Revel, M. & Chebath, J. (1985) 3′ end structure of the human (2′-5′) oligo A synthetase gene: prediction of two distinct proteins with cell type-specific expression. Nucleic Acids Res. 13, 1267-1281.
39. 39. Benech, P., Mory, Y., Revel, M. & Chebath, J. (1985) Structure of two forms of the interferon-induced (2′-5′) oligo A synthetase of human cells based on cDNAs and gene sequences. EMBO J. 4, 2249-2256.
40. 40. Saunders, M.E., Gewert, D.R., Tugwell, M.E., McMahon, M. & Williams, B.R. (1985) Human 2-5A synthetase: characterization of a novel cDNA and corresponding gene structure. EMBO J. 4, 1761-1768.
41. 41. Marié, I. & Hovanessian, A.G. (1992) The 69-kDa 2-5A synthetase is composed of two homologous and adjacent functional domains. J. Biol. Chem. 267, 9933-9939.
42. 42. Hovnanian, A., Rebouillat, D., Mattei, M.G., Levy, E.R., Marié, I., Monaco, A.P. & Hovanessian, A.G. (1998) The Human 2′-5′ oligoadenylate synthetase locus is composed of three distinct genes clustered on chromosome 12q24.2 encoding the 100, 69 and 40 kDa forms. Genomics 52, 267-277.
43. 43. Rebouillat, D., Hovnanian, A., Marié, I. & Hovanessian, A.G. (1999) The 100-kDa 2′-5′ oligoadenylate synthetase catalyzing the preferential synthesis of dimeric 2-5A molecules is composed of three homologous domains. J. Biol. Chem. 274, 1557-1565.
44. 44. Witt, P.L., Marié, I., Robert, N., Irizarry, A., Borden, E.C. & Hovanessian, A.G. (1993) Isoforms p69 and p100 of 2′,5′-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro. J. Interferon Res. 13, 17-23.
45. 45. Dubois, M.F. & Hovanessian, A.G. (1990) Modified subcellular localization of interferon-induced p68 kinase during encephalomyocarditis virus infection. Virology 179, 591-598.
46. 46. Marié, I., Svab, J., Robert, N., Galabru, J. & Hovanessian, A.G. (1990) Differential expression and distinct structure of 69- and 100-kDa forms of 2-5A synthetase in human cells treated with Interferon. J. Biol. Chem. 265, 18601-18607.
47. 47. Besse, S., Rebouillat, D., Marié, I., Puvion-Dutilleul, F. & Hovanessian, A.G. (1998) Ultrastructural localization of interferon-inducible double-stranded RNA-activated enzymes in human cells. Exp. Cell. Res. 239, 379-392.
48. 48. Marié, I., Blanco, J., Rebouillat, D. & Hovanessian, A.G. (1997) 69-kda and 100-kda isoforms of interferon-induced (2′-5′) oligoadenylate synthetase exhibit differential catalytic parameters. Eur. J. Biochem. 248, 558-566.
49. 49. Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M. & Arai, N. (1988) SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8, 466-472.
50. 50. Stemmer, W.P.C. & Morris, S.K. (1992) Enzymatic inverse PCR: a restriction site independent, single-fragment method for high-efficiency, site-directed mutagenesis. Biofeedback 13, 215-220.
51. 51. Sambrook, J., Fritsch, E.F. & Maniatis, T. (1989) Molecular cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring, Harbor. NY.
52. 52. Hide, I., Toriu, N., Nuibe, T., Inoue, A., Hide, M. & Yamamoto and Nakata, Y. (1997) Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation. J. Immunol. 159, 2932-2940.
53. 53. Miele, M.B., Liu, D.K. & Kan, N.C. (1991) Fractionation and characterization of 2′,5′-oligoadenylates by polyacrylamide gel electrophoresis: an alternative method for assaying 2′,5′-oligoadenylate synthetase. J. Interferon Res. 11, 33-40.
54. 54. Milhaud, P.G., Silhol, M., Faure, T. & Milhaud, X. (1983) Numerical tables for the direct estimation of virus titres by the maximum likelihood method. Ann. Virol. (Inst. Pasteur) 134E, 405-416.
55. 55. Marié, I., Galabru, J., Svab, J. & Hovanessian, A.G. (1989) Preparation and characterization of polyclonal antibodies specific for the 69 and 100 k-Dalton forms of human 2-5A synthetase. Biochem. Biophys. Res. Commun. 160, 580-587.
56. 56. Hovanessian, A.G. & Kerr, I.M. (1978) Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells. Eur. J. Biochem. 84, 149-159.
57. 57. Meurs, E.F., Watanabe, Y., Kadereit, S., Barber, G.N., Katze, M.G., Chong, K., Williams, B.R. & Hovanessian, A.G. (1992) Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66, 5804-5814.
58. 58. Sarkar, S.N., Bandyopadhyay, S., Ghosh, A. & Sen, G.C. (1999) Enzymatic characteristics of recombinant medium isozyme of 2′-5′ oligoadenylate synthetase. J. Biol. Chem. 274, 1848-1855.
59. 59. Ghosh, S.K., Kusari, J., Bandyopadhyay, S.K., Samanta, H., Kumar, R. & Sen, G.C. (1991) Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylate synthetases. Structure-function relationships. J. Biol. Chem. 266, 15293-15299.
60. 60. Ghosh, A., Sarkar, S.N., Guo, W.D., Bandyopadhyay, S. & Sen, G.C. (1997) Enzymatic activity of 2′-5′-oligoadenylate synthetase is impaired by specific mutations that affect oligomerization of the protein. J. Biol. Chem. 272, 33220-33226.
61. 61. Ghosh, A., Sarkar, S.N., Bandyopadhyay, S. & Sen, G.C. (1997) Oligomerization of the 2-5 (A) synthetase proteins is essential for their enzyme activity. J. Interferon Cytokine Res. 17/S2, 51.